Investors

News Release

<< Back
Codexis to Announce Third Quarter 2012 Financial Results on November 7, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 24, 2012-- Codexis, Inc. (NASDAQ: CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceuticals, today announced it will host a conference call and webcast on Wednesday, November 7, 2012 at 4:30 p.m. Eastern Time to discuss its third quarter 2012 financial results for the period ended September 30, 2012. The call and webcast will follow the release of third quarter financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.

     
What: Codexis' third quarter 2012 financial results conference call and webcast
 

Date:

Wednesday, November 7, 2012
 

Time:

4:30 p.m. ET
 

Live Call:

US: 866-788-0541
International: 857-350-1679
Passcode: 54501345
 

Replay:

US: 888-286-8010
International: 617-801-6888
Passcode: 65902545
 

About Codexis, Inc.

Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals. Codexis' product lines include CodeXyme™ cellulase enzymes and CodeXol™ detergent alcohol. Partners and customers include global leaders such as Merck, Pfizer and Teva. For more information, see www.codexis.com.

Source: Codexis, Inc.

Codexis, Inc.
Investors:
Paul Cox, 212-362-1200
ir@codexis.com
Media:
Kelly McAlearney, 415-503-4073
media@codexis.com

Print Page Print Page | E-mail Page E-mail Page |

Share Page

X
| Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSIS®

We are an industrial biotechnology company providing unique, state-of-the-art enzyme optmization services and biocatalyst products.


BIOCATALYSIS PRODUCTS

Codexis offers complete biocatalysis solutions from “off-the-shelf” enzymes and Screening Kits, to commercial supply of biocatalysts.

CODEXIS

CODEEVOLVER®


Our protein engineering technology enables the rapid development of custom-designed enzymes

CODEXIS

MEDIA CENTER


Visit our Media Center for the latest press information, videos, imagery, and technical papers.

CAREERS AT CODEXIS

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information for the investment community


built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue